FDA Panel Backs Wider Use of Drug to Treat Early Stage Breast Cancer
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Researchers looked at 30 years of data from all 50 statesContinue Reading
159 cases reported so far this year in unvaccinated peopleContinue Reading
Already approved for cosmetic ‘frown lines’Continue Reading
However, cosmetic improvement is only temporaryContinue Reading
DS-Connect offers a centralized, secure online resource to store and share health informationContinue Reading
Campaigns focusing on dangers, risks might not work when you feel invincible, study suggestsContinue Reading
Hispanic patients had lowest death rates after subarachnoid stroke, study foundContinue Reading
Make sure equipment is age-appropriateContinue Reading
New record-keeping method may help improve diabetes care, tracking of childhood growth disorders, studies sayContinue Reading
Label warnings designed to limit use of extended-release, long-acting drugs like OxycontinContinue Reading
Different approach to classes needed in urban areas, researchers sayContinue Reading
Perjeta might gain quick FDA approvalContinue Reading
Racial disparity greatest among those in professional, management positions, researchers say
Continue Reading
© 2021 TheHealthCast.com - All Rights Reserved.